This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.

中文翻译：

---

索马鲁肽在精神病学中的机遇与挑战


本观点讨论了胰高血糖素样肽 1 受体激动剂用于治疗精神科药物引起的体重增加和心血管疾病风险的临床试验结果。